PATHOLOGICAL OUTCOME OF HER2/NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY. FMHR [Internet]. 2025 Sep. 2 [cited 2026 Oct. 10];3(7):1552-8. Available from: https://fmhr.net/index.php/fmhr/article/view/1887